Connect with us

Health

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death – CNA

The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.

Published

on

post featured image

GENEVA: The World Health Organization (WHO) said on Saturday (Jul 4) that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospit…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending